Skip to content

Clinical trials

Phase 4 Osteoporosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Phase: Phase 4 Country / region: United States Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20021
20032
20043
20055
20064
20075
20083
20093
20102
20111
20121
20133
20141
20152
20162
20171
20181
20192
20202
20212
20222
20233
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Active, not recruiting6
Recruiting5
Unknown status3
Terminated2
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company6
Susan L. Greenspan5
Massachusetts General Hospital4
University of Wisconsin, Madison4
James J. Peters Veterans Affairs Medical Center3
University of Alabama at Birmingham3
GlaxoSmithKline2
Novartis Pharmaceuticals2
Amgen1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis60
Bone Diseases, Metabolic19
Osteoporosis, Postmenopausal9
Spinal Cord Injuries4
Fractures, Bone3
Frailty3
Osteoporotic Fractures3
Breast Neoplasms2
Hypercalcemia2
Achlorhydria1

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.